Regulus Therapeutics Inc (DELISTED) (RGLS:DL)
8.16
0.00 (0.00%)
USD |
NASDAQ |
Jun 30, 16:00
Regulus Therapeutics Total Liabilities (Quarterly): 5.798M for March 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 6.033B |
| SpringWorks Therapeutics Inc (DELISTED) | 87.96M |
| CorMedix, Inc. | 376.73M |
| BioCardia, Inc. | 3.521M |
| Xeris Biopharma Holdings, Inc. | 371.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 74.83M |
| Shareholders Equity (Quarterly) | 69.03M |